OrbiMed Healthcare raises $4.3b over three funds

OrbiMed, the renowned global healthcare investment firm, has successfully secured over $4.3 billion in commitments for its latest private investment funds. The newly unveiled funds—OrbiMed Private Investments IX, OrbiMed Asia Partners V, and OrbiMed Royalty & Credit Opportunities IV—position OrbiMed to make strategic global investments, spanning from seed-stage support for start-ups nurtured within the OrbiMed ecosystem.

This significant capital raise further solidifies OrbiMed's commitment to fostering innovation and growth across the healthcare sector. Drawing on the firm's expertise and a track record of success, these funds are poised to drive impactful investments in healthcare ventures worldwide.